Pages that link to "Q43179454"
Jump to navigation
Jump to search
The following pages link to Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in (Q43179454):
Displaying 41 items.
- Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials (Q26785723) (← links)
- Anti‐platelet therapy: phosphodiesterase inhibitors (Q27687228) (← links)
- Novel agents for anti-platelet therapy (Q35574825) (← links)
- Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy Ac (Q36036395) (← links)
- Effect of premedication method and drug resistance of antiplatelet agent on periprocedural thromboembolic events during coil embolization of an unruptured intracranial aneurysm (Q36377518) (← links)
- Adjunctive cilostazol versus high maintenance dose of clopidogrel in patients with hyporesponsiveness to chronic clopidogrel therapy (Q36463997) (← links)
- Clopidogrel in acute coronary syndrome: implications of recent study findings (Q37786639) (← links)
- Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management. (Q37809122) (← links)
- Clinical Value of Antiplatelet Therapy in Patients with Acute Coronary Syndromes and in Percutaneous Coronary Intervention (Q37841560) (← links)
- Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions (Q37870035) (← links)
- Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention (Q37880741) (← links)
- Antiplatelet Drug Therapy: Role of Pharmacodynamic and Genetic Testing (Q37882712) (← links)
- The evolution of antiplatelet therapy in cardiovascular disease (Q37900470) (← links)
- Thienopyridine-Associated Drug-Drug Interactions: Pharmacologic Mechanisms and Clinical Relevance (Q37914050) (← links)
- Antiplatelet agents for the treatment and prevention of atherothrombosis (Q37948506) (← links)
- Latest Evidence in Personalized Antiplatelet Therapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (Q38012079) (← links)
- Use of cilostazol in percutaneous coronary interventions (Q38016384) (← links)
- Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives (Q38018679) (← links)
- Cilostazol-Based Triple Antiplatelet Therapy Compared to Dual Antiplatelet Therapy in Patients with Coronary Stent Implantation: A Meta-Analysis of 5,821 Patients (Q38029492) (← links)
- The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: from aspirin to the present day. (Q38053481) (← links)
- Comparison of on-treatment platelet reactivity between triple antiplatelet therapy with cilostazol and standard dual antiplatelet therapy in patients undergoing coronary interventions: a meta-analysis (Q38122999) (← links)
- Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties. (Q38151563) (← links)
- Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials (Q38215543) (← links)
- The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes (Q40225108) (← links)
- The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients (Q41551745) (← links)
- Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials (Q41875999) (← links)
- Comparison of Platelet P2Y12 ADP Receptor-Mediated Pathway Inhibition in Triple Versus Dual Antiplatelet Therapy as Assessed by VASP-Phosphorylation in Japanese Patients Undergoing Coronary Stenting (Q42850846) (← links)
- Cilostazol augments the inhibition of platelet aggregation in clopidogrel low-responders (Q42932504) (← links)
- Tailoring antiplatelet therapy in acute coronary syndromes: the thin red line (Q44397962) (← links)
- Platelet-Derived Microparticles and Platelet Function Profile in Children With Congenital Heart Disease (Q46094023) (← links)
- Effect of cilostazol on platelet reactivity among patients with peripheral artery disease on clopidogrel therapy. (Q50163343) (← links)
- Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting. (Q53118529) (← links)
- Atherothrombosis and the role of antiplatelet therapy (Q57243374) (← links)
- Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis (Q58768916) (← links)
- The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study (Q59807214) (← links)
- Stent thrombosis: understanding and managing a critical problem (Q83117953) (← links)
- No Role for Triple Antiplatelet Therapy? (Q83200538) (← links)
- A meta-analysis of randomized trials of triple versus dual antiplatelet therapy after stent-based percutaneous coronary intervention (Q84258124) (← links)
- Carotid artery stenting using the proximal or dual protection method for near occlusion of the cervical internal carotid artery (Q86993176) (← links)
- Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases (Q89169483) (← links)
- In vivo assessment of anticoagulant and antiplatelet effects of Syzygium cumini leaves extract in rabbits (Q93083017) (← links)